Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for FSD Pharma Inc. (HUGE)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
2 weeks ago | Proactive Investors
2 weeks ago | Business Wire
2 months ago | Proactive Investors
2 months ago | Business Wire
3 months ago | Proactive Investors
3 months ago | Business Wire
3 months ago | Business Wire
3 months ago | Newsfile Corp
3 months ago | Proactive Investors
3 months ago | Business Wire
About:
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada.